Identification of Lysins and Derivatives Thereof With Bactericidal Activity Against
Copyright © Targeted News Service 2024
2024-10-22
ALEXANDRIA, Virginia, Oct. 22 -- AUROBAC THERAPEUTICS SAS, Lyons, France has been assigned a patent (No. US 12121568 B2, initially filed Dec. 12, 2018) developed by Raymond Schuch, Mountain Lakes, New Jersey, and Chiara Indiani, Metuchen, New Jersey, for "Identification of lysins and derivatives thereof with bactericidal activity against ." . . .